Skip to content

Observation on the application effect of Remimazolam Tosilate in induction of general anesthesia in elderly patients

Observation on the application effect of Remimazolam Tosilate in induction of general anesthesia in elderly patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083990
Enrollment
Unknown
Registered
2024-05-08
Start date
2024-05-10
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia induction

Interventions

0.25mg/kg Remimazolam Tosilate group:Intravenous injection of different doses of Remimazolam Tosilate
Remimazolam 0.30mg/kg:Remimazolam 0.30mg/kg,
Remimazolam 0.35mg/kg Group:Remimazolam 0.35mg/kg
Remimazolam 0.40mg/kg Group:Remimazolam 0.40mg/kg

Sponsors

Jiaxing Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age =65 years old; 2) The American Association of Anesthesiologists (ASA) has a physical status rating of II-III; 3) 18 kg/m2<BMI<30 kg/m2 ; 4) hysteroscopic general anesthesia; 5) Understand clearly and voluntarily participate in the study, and sign the informed consent form by myself or my family.

Exclusion criteria

Exclusion criteria: 1) Patients who are allergic to benzodiazepines; 2) Patients with myasthenia gravis; 3) patients with schizophrenia; 4) Patients with severe depression; 5) Hypertension is not controlled (preoperative systolic blood pressure =160mmHg) and diabetes is not controlled (=11.1mmol/L).

Design outcomes

Primary

MeasureTime frame
Intubation stress reaction (jaw relaxation, no body movement);Hemodynamic changes;

Secondary

MeasureTime frame
blood pressureHR;SPO2;Anesthetic effects;Psychomotor recovery;

Countries

China

Contacts

Public ContactQiang Xu;Wang Ping Zhang

Jiaxing Maternal and Child Health Care Hospital

xuqiang0920@126.com+86 157 1263 2322

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026